A virtual bank for collecting and sharing mesothelioma patient data and samples.
Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24) - 2021
This study is gathering blood and tissue samples from people with mesothelioma to help researchers learn more about the disease and find better treatments, and they're looking to include more patients from different backgrounds to make the research even more helpful.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10849611 on NIH RePORTER |
What this research studies
The National Mesothelioma Virtual Bank (NMVB) collects biospecimens such as blood and tissue from patients diagnosed with mesothelioma, along with their demographic and clinical information. This data is shared with researchers to advance understanding and treatment of mesothelioma. The project aims to expand the patient cohort to 2,200 individuals and enhance the diversity of the data collected. Additionally, the NMVB seeks to automate the annotation of biospecimens using electronic health records to improve research efficiency.
Who could benefit from this research
Good fit: Ideal candidates for participation are individuals diagnosed with mesothelioma who are willing to provide biospecimens and clinical information.
Not a fit: Patients who do not have a diagnosis of mesothelioma or are unwilling to provide biospecimens may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and outcomes for patients with mesothelioma.
How similar studies have performed: Previous research initiatives involving biobanks have shown success in advancing cancer research, indicating that this approach is promising.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Becich, Michael John — University of Pittsburgh at Pittsburgh
- Study coordinator: Becich, Michael John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.